StonvexLoading…
StonvexStonvexStonvexCore line items from RCMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-03 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $319.40M | $278.38M | $263.24M | $284.68M |
Operating Income | $25.09M | $22.32M | $23.69M | $28.80M |
Net Income | $16.33M | $13.33M | $16.83M | $20.89M |
EPS (Diluted) | $2.14 | $1.68 | $1.96 | $2.00 |
Total Assets | $134.40M | $132.08M | $120.48M | $87.96M |
Total Liabilities | $88.42M | $98.59M | $94.69M | $56.00M |
Cash & Equivalents | $2.92M | $4.73M | $6.28M | $339.00K |
Free Cash Flow OCF − CapEx | $17.37M | $3.60M | $9.55M | $27.39M |
Shares Outstanding | 7.35M | 7.60M | 7.84M | 9.29M |